Bristol-Myers Squibb Company (BMY) Stock Prediction 2026
Bristol-Myers Squibb Company is scored daily by TradeWell’s model ensemble. The TW Quant Score below is the model’s conviction percentile among 4,049 scored stocks on the 1Y horizon — one of 10 horizons (1D to 5Y) scored for every covered stock.
TW Quant Score is research, not investment advice. It is not a recommendation to buy or sell any security. Predictions can be wrong. Past model performance does not guarantee future results.
As of October 7, 2026, Bristol-Myers Squibb Company ranks #668 of 4,049 scored stocks on the 1Y horizon.
Signal breakdown — as of October 7, 2026
Each signal is scored 0–100. A dash means the signal was not computed for BMY on this scan — TradeWell discloses missing data rather than printing a fake zero.
| Trend | 36 |
| Momentum | 0 |
| Volume | 0 |
| Pattern | 92 |
| Insider activity | 50 |
| News sentiment | 57 |
| Seasonality | 47 |
| Macro / sector | 47 |
| Mean reversion | 21 |
| Fundamental | 80 |
Expected return and price target
Model expected returns and model-implied price targets for Bristol-Myers Squibb Company across all 10 horizons are published in the app and refreshed daily. They are not reproduced on this page.
How this prediction is built
A multi-model ensemble (Ridge, XGBoost, LightGBM, and deeper research models) ranks 2,800+ stocks daily per horizon; predictions are tracked and graded against real outcomes. Method details: methodology. All prediction pages: index.